Elon Musk‘s alleged partying and drug use with Tesla Inc (NASDAQ:TSLA) board members might be causing discomfort among investors, but these issues are overshadowing more significant execution problems at the company, according to a long-time Tesla shareholder. What Happened: Ross Gerber, CEO of Gerber Kawasaki Wealth and Investment Management, pointed to a recent Wall Street Journal report that suggested Musk had used drugs with his executives. This, he said, could be a deterrent to institutional investors, reported Business Insider on Monday. Gerber said that these allegations, along with Mus…
